Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9676 - 9700 of 9783 in total
Lintitript is a new, highly specific and potent CCK-A receptor antagonist.
Investigational
Investigational
Vinpocetine has been investigated for the treatment of Epilepsy.
Investigational
Investigational
Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to...
Investigational
Matched Categories: … Membrane Transport Modulators …
Niludipine is a calcium channel blocker.
Experimental
Matched Categories: … Membrane Transport Modulators …
Investigational
Liothyronine I-131 has been used in trials studying the treatment of Tricuspid Atresia and Heart Defects, Congenital.
Investigational
RWJ-800088 is a synthetic PEGylated thrombopoietin (TPO) mimetic (TPOm) peptide with no sequence homology to endogenous TPO.
Investigational
Vintafolide is a folate-targeted chemotherapeutic conjugate (folate vitamin + vinca alkaloid) in clinical stage development as a treatment for folate-receptor positive cancers.
Investigational
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
Investigational
Displaying drugs 9676 - 9700 of 9783 in total